Company intelligence
Cencora | Pharma solutions
At Cencora, we are investing and innovating alongside our pharma customers to unlock their product’s potential.
About Cencora | Pharma solutions
At Cencora, we are investing and innovating alongside our pharma customers to unlock their product’s potential. Cencora is a leading global pharmaceutical solutions organization centered on improving lives. We partner with pharmaceutical innovators and care providers to facilitate access to pharmaceuticals and healthcare products. Our pharma solutions — ranging from support during drug discovery to lifecycle management — help pharmaceutical and biopharma companies of all sizes reach full product potential. Previously known as AmerisourceBergen, our 46,000+ Cencora team members power our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.Cencora.com.
Verified activity
Signals from Cencora | Pharma solutions
8 published signals
Presence & Recognition
Cencora | Pharma solutions is participating in the LORENZ Converge event taking place September 14 - 16 in Frankfurt, Germany, featuring featured sessions on AI transforming scientific authoring and ICH M4Q(R2) quality guidelines.
Reported by Cencora | Pharma solutions
Research & Knowledge
Cencora | Pharma solutions published an article by Louis Cicchini, PhD, Senior Director of Scientific Affairs & Strategic Partnerships for CGT, and Stephen Sun, MD, VP of Pharmacovigilance, exploring why pharmacovigilance is becoming a strategic driver for cell and gene therapy success.
Reported by Cencora | Pharma solutions
Research & Knowledge
Cencora | Pharma solutions reported positive Phase 3 data for a therapy targeting post-bariatric hypoglycemia.
Reported by Eric Monzon
Research & Knowledge
Cencora | Pharma solutions reported new late-stage clinical data showing an mRNA-based personalized cancer therapy delivering improved outcomes in combination with established immunotherapy.
Reported by Eric Monzon
Research & Knowledge
Cencora | Pharma solutions reported a recent high-profile acquisition in the rare disease space reinforcing the strategic importance of small patient populations.
Reported by Eric Monzon
Presence & Recognition
Cencora | Pharma solutions held a webinar replay titled Thinking like a regulator: De-risking first-cycle submission review to discuss internal processes and organizational structures as barriers to achieving an integrated view earlier in the development cycle.
Reported by Cencora | Pharma solutions
Research & Knowledge
Cencora | Pharma solutions published a white paper detailing insights from supporting 200+ manufacturers from launch planning and distribution to market access and growth.
Reported by Cencora | Pharma solutions
Presence & Recognition
Cencora | Pharma solutions is attending the World Drug Safety Congress Europe in Amsterdam from 22 to 24 September 2026 alongside its Pharmacovigilance and Digital Innovation teams.
Reported by Igor Dorosh